Arcturus Therapeutics Holdings Inc (ARCT)
23.89
-0.87
(-3.51%)
USD |
NASDAQ |
Oct 04, 16:00
23.26
-0.63
(-2.64%)
Pre-Market: 20:00
Arcturus Therapeutics Holdings Shareholders Equity (Annual): 278.51M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 278.51M |
| December 31, 2022 | 270.31M |
| December 31, 2021 | 228.21M |
| December 31, 2020 | 396.55M |
| December 31, 2019 | 25.79M |
| December 31, 2018 | 13.64M |
| December 31, 2017 | 33.79M |
| Date | Value |
|---|---|
| December 31, 2016 | 1.577M |
| December 31, 2015 | 69.33M |
| December 31, 2014 | 19.94M |
| December 31, 2013 | 48.69M |
| December 31, 2012 | -0.567M |
| December 31, 2011 | 0.985M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
25.79M
Minimum
2019
396.55M
Maximum
2020
239.88M
Average
270.31M
Median
2022
Shareholders Equity (Annual) Benchmarks
| Fulcrum Therapeutics Inc | 235.19M |
| Bioventus Inc | 173.59M |
| Semler Scientific Inc | 71.80M |
| Liquidia Corp | 47.29M |
| AIM ImmunoTech Inc | 10.23M |